Lixia Yu

945 total citations
39 papers, 716 citations indexed

About

Lixia Yu is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Lixia Yu has authored 39 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 10 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Lixia Yu's work include Parathyroid Disorders and Treatments (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Dialysis and Renal Disease Management (8 papers). Lixia Yu is often cited by papers focused on Parathyroid Disorders and Treatments (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Dialysis and Renal Disease Management (8 papers). Lixia Yu collaborates with scholars based in China, Germany and United States. Lixia Yu's co-authors include Qifeng Liu, Shasha Li, Jianming Ye, Wen‐Jing Hu, Xiaoping Qian, Jing Sun, Jianhua Feng, Xiaohong Dong, Xiaoxia Gu and Qiuxia Lin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Nutrients and Metabolism.

In The Last Decade

Lixia Yu

34 papers receiving 709 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lixia Yu 336 266 103 83 80 39 716
Wenjun Lin 216 0.6× 376 1.4× 86 0.8× 75 0.9× 47 0.6× 43 750
Lirong Hao 199 0.6× 287 1.1× 86 0.8× 91 1.1× 57 0.7× 34 763
Masahiko Kushiro 231 0.7× 121 0.5× 52 0.5× 65 0.8× 60 0.8× 13 675
Krishna R. Polu 551 1.6× 319 1.2× 94 0.9× 62 0.7× 87 1.1× 17 907
Kevin B. Atkins 158 0.5× 439 1.7× 79 0.8× 109 1.3× 48 0.6× 23 890
Jili Zhu 299 0.9× 244 0.9× 88 0.9× 54 0.7× 62 0.8× 19 595
Steven Radoff 306 0.9× 264 1.0× 97 0.9× 105 1.3× 180 2.3× 15 1.5k
Minseob Eom 104 0.3× 352 1.3× 69 0.7× 89 1.1× 50 0.6× 45 797
Congwei Luo 272 0.8× 529 2.0× 50 0.5× 113 1.4× 77 1.0× 22 1.0k
Chi Liu 162 0.5× 411 1.5× 61 0.6× 77 0.9× 42 0.5× 39 834

Countries citing papers authored by Lixia Yu

Since Specialization
Citations

This map shows the geographic impact of Lixia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Yu more than expected).

Fields of papers citing papers by Lixia Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Yu. The network helps show where Lixia Yu may publish in the future.

Co-authorship network of co-authors of Lixia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixia Yu. A scholar is included among the top collaborators of Lixia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixia Yu. Lixia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Bei, et al.. (2025). Therapeutic Potential of hucMSC‐EVs in Diabetic Kidney Disease via Regulating the miR‐146b‐5p/Merlin/YAP Axis. Stem Cells International. 2025(1). 5243270–5243270.
3.
Yu, Lixia, et al.. (2025). Easing Youth Career Distress: Impacts of Future Work Self Salience, Goal Engagement, and Calling Motivation. Journal of Career Development. 52(6). 818–836.
4.
Xue, Zi, Xi Liu, Qifeng Liu, Xiaoyi Yang, & Lixia Yu. (2025). A disproportionality analysis of adverse events associated with loop diuretics in the FDA Adverse Event Reporting System (FAERS). BMC Pharmacology and Toxicology. 26(1). 63–63.
5.
Yu, Lixia, et al.. (2024). Bridging the Gender Gap in Academic Engagement among Young Adults: The Role of Anticipated Future Sex Discrimination and Gender-role Orientation. Journal of Youth and Adolescence. 53(10). 2192–2201. 1 indexed citations
6.
Wang, Rui, Tieqiang Sun, Yuxian Zhang, et al.. (2024). Vitamin B6 alleviates chronic sleep deprivation-induced hippocampal ferroptosis through CBS/GSH/GPX4 pathway. Biomedicine & Pharmacotherapy. 174. 116547–116547. 12 indexed citations
7.
Li, Shasha, et al.. (2022). Abnormally decreased renal Klotho is linked to endoplasmic reticulum-associated degradation in mice. International Journal of Medical Sciences. 19(2). 321–330. 5 indexed citations
8.
Liu, Qifeng, et al.. (2022). CCL5 Suppresses Klotho Expression via p-STAT3/DNA Methyltransferase1-Mediated Promoter Hypermethylation. Frontiers in Physiology. 13. 856088–856088. 10 indexed citations
9.
Liu, Qifeng, et al.. (2021). Correlation Between Soluble Klotho and Vascular Calcification in Chronic Kidney Disease: A Meta-Analysis and Systematic Review. Frontiers in Physiology. 12. 711904–711904. 14 indexed citations
10.
Yu, Lixia, Ling Li, Tingting Bai, et al.. (2018). Activation of autophagy contributes to the renoprotective effect of postconditioning on acute kidney injury and renal fibrosis. Biochemical and Biophysical Research Communications. 504(4). 641–646. 32 indexed citations
11.
Liu, Qifeng, Jianming Ye, Lixia Yu, et al.. (2016). Klotho mitigates cyclosporine A (CsA)-induced epithelial–mesenchymal transition (EMT) and renal fibrosis in rats. International Urology and Nephrology. 49(2). 345–352. 33 indexed citations
12.
Zhang, Yanqin, Fang Wang, Jie Ding, et al.. (2015). Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome. Pediatric Nephrology. 31(1). 67–72. 20 indexed citations
13.
Wang, Fang, Jie Ding, Hongwen Zhang, et al.. (2014). [Comparison of phenotypic features between patients with X-linked and autosomal recessive Alport syndrome].. PubMed. 46(2). 311–4. 1 indexed citations
14.
Yu, Lixia, Yanbo Liu, Yanfeng Wu, et al.. (2014). Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage. Cellular Signalling. 26(12). 2979–2991. 29 indexed citations
15.
Wang, Fang, Jie Ding, Hongwen Zhang, et al.. (2012). Skin Biopsy Is a Practical Approach for the Clinical Diagnosis and Molecular Genetic Analysis of X-Linked Alport's Syndrome. Journal of Molecular Diagnostics. 14(6). 586–593. 30 indexed citations
16.
Zhang, Hongwen, Jie Ding, Fang Wang, & Lixia Yu. (2012). Attitudes toward genetic diagnosis and prenatal diagnosis of X‐linked Alport syndrome in China. Nephrology. 17(4). 398–401. 3 indexed citations
17.
Yu, Lixia, Qiuxia Lin, Jianhua Feng, et al.. (2012). Inhibition of nephrin activation by c-mip through Csk–Cbp–Fyn axis plays a critical role in Angiotensin II-induced podocyte damage. Cellular Signalling. 25(3). 581–588. 25 indexed citations
18.
Yu, Lixia, Qiuxia Lin, Hua Liao, et al.. (2010). TGF-β1 Induces Podocyte Injury Through Smad3-ERK-NF-κB Pathway and Fyn-dependent TRPC6 phosphorylation. Cellular Physiology and Biochemistry. 26(6). 869–878. 38 indexed citations
19.
20.
Ding, Jie, et al.. (1997). Alport syndrome with neurofibromatosis type-I: a case report. Pediatric Nephrology. 11(5). 649–650. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjun Lin Breakdown of academic impact, for papers by Lirong Hao Breakdown of academic impact, for papers by Masahiko Kushiro Breakdown of academic impact, for papers by Krishna R. Polu Breakdown of academic impact, for papers by Kevin B. Atkins Breakdown of academic impact, for papers by Jili Zhu Breakdown of academic impact, for papers by Steven Radoff Breakdown of academic impact, for papers by Minseob Eom Breakdown of academic impact, for papers by Congwei Luo Breakdown of academic impact, for papers by Chi Liu
Rankless by CCL
2026